Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LABORATORY SERVICES OF AMERICA LLC

NPI: 1871841130 · LAS VEGAS, NV 89169 · Clinical Medical Laboratory · NPI assigned 08/16/2012

$203K
Total Medicaid Paid
32,527
Total Claims
29,695
Beneficiaries
43
Codes Billed
2018-01
First Month
2021-03
Last Month

Provider Details

Authorized OfficialKOTHURU, RAKESH (MANAGING PARTNER)
NPI Enumeration Date08/16/2012

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 27,587 $107K
2019 4,366 $92K
2020 527 $3K
2021 47 $630.88

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 1,943 1,821 $67K
80363 1,067 982 $15K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 1,418 986 $14K
80372 1,162 1,064 $9K
80373 1,162 1,065 $9K
80356 1,072 988 $8K
80361 1,173 1,073 $8K
80365 1,167 1,067 $8K
80348 1,164 1,065 $8K
80354 1,165 1,066 $8K
80358 1,174 1,074 $8K
80337 766 709 $4K
80325 781 727 $4K
80369 190 179 $3K
80352 756 698 $3K
80366 791 739 $3K
80355 793 743 $3K
80349 853 791 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 207 155 $2K
80360 860 800 $2K
80359 869 807 $2K
80346 868 805 $2K
80353 865 802 $2K
80321 780 720 $2K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 568 421 $2K
80345 838 778 $2K
80368 776 720 $2K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 515 507 $2K
80371 748 694 $1K
83992 836 773 $1K
80367 1,155 1,057 $104.57
80323 581 544 $33.00
80344 513 479 $30.98
80334 420 401 $29.70
80370 576 542 $17.54
80357 576 541 $16.50
80338 433 408 $16.50
80375 423 404 $16.21
80339 420 401 $14.75
80340 30 29 $0.00
80324 29 28 $0.00
80364 30 29 $0.00
80326 14 13 $0.00